Literature DB >> 19359917

Characterization of persistent hyperglycemia: what does it mean postinjury?

Jason L Sperry1, Heidi L Frankel, Avery B Nathens, Grant E O'keefe, Joseph Cuschieri, Ernest E Moore, Ronald V Maier, Joseph P Minei.   

Abstract

BACKGROUND: Strict glycemic control has been shown to reduce both morbidity and mortality in critically ill surgical patients; however, overly aggressive management of hyperglycemia may also be associated with deleterious effects. We sought to characterize clinical outcomes associated with different levels of persistent hyperglycemia (PH) in a cohort of severely injured patients with trauma, when a strict glycemic control protocol (target glucose 80-110 mg/dL) was implemented.
METHODS: Data were obtained from a multicenter prospective cohort study evaluating clinical outcomes in blunt injured adults with hemorrhagic shock. Glycemic control was analyzed using the average maximum daily glucose values from postinjury day 2 (>48 hours after injury) to postinjury day 5. PH was defined as a mean glucose value >130 mg/dL, and was categorized into three different severity levels (I-III) based on the distribution of mean 4-day glucose values for the cohort. Separate Cox proportional hazard regression models were then used to determine whether PH was independently associated with mortality and nosocomial infection (NI), and the level of glycemic control that was associated with these poor outcomes.
RESULTS: Overall mortality and NI rates for the study population (n = 862) were 10.8% and 49.6%, respectively. Cox proportional hazard regression revealed that PH was independently associated with almost an 80% higher mortality in patients with mean 4-day glucose values >145 mg/dL (group II) and almost a twofold higher mortality in patients with >165 mg/dL (group III). However, PH was not independently associated with a higher risk of NI at any level. Patients with PH did have a higher incidence of early multiple organ failure (within first 48 hours: 30.2% vs. 41.6% p = 0.001), which preceded the documentation of PH in the majority of patients.
CONCLUSION: Maintenance of daily maximum glucose values <145 mg/dL was independently associated with a survival benefit after injury. Patients with PH, despite aggressive insulin therapy, had a higher incidence of multiple organ failure and an associated higher risk of mortality. However, the strict glycemic control protocol in the current trauma cohort seems to have prevented the association of PH and infectious complications, which has been documented in prior studies. This analysis further validates the importance of strict glycemic control after injury, and highlights the need for further studies on the mechanism responsible for these findings.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19359917      PMCID: PMC4004069          DOI: 10.1097/TA.0b013e31817db0de

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  28 in total

1.  Organ dysfunction as an outcome measure in clinical trials.

Authors:  J C Marshall
Journal:  Eur J Surg Suppl       Date:  1999

2.  TrialDB: A web-based Clinical Study Data Management System.

Authors:  C A Brandt; A M Deshpande; C Lu; G Ananth; K Sun; R Gadagkar; R Morse; C Rodriguez; P L Miller; P M Nadkarni
Journal:  AMIA Annu Symp Proc       Date:  2003

3.  Early hyperglycemia predicts multiple organ failure and mortality but not infection.

Authors:  Jason L Sperry; Heidi L Frankel; Sue L Vanek; Avery B Nathens; Ernest E Moore; Ronald V Maier; Jospeh P Minei
Journal:  J Trauma       Date:  2007-09

Review 4.  The stress response to surgical trauma: from physiological basis to therapeutic implications.

Authors:  K J Anand
Journal:  Prog Food Nutr Sci       Date:  1986

5.  Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes.

Authors:  Guillermo E Umpierrez; Scott D Isaacs; Niloofar Bazargan; Xiangdong You; Leonard M Thaler; Abbas E Kitabchi
Journal:  J Clin Endocrinol Metab       Date:  2002-03       Impact factor: 5.958

6.  Multiple-organ-failure syndrome.

Authors:  C J Carrico; J L Meakins; J C Marshall; D Fry; R V Maier
Journal:  Arch Surg       Date:  1986-02

7.  Pancreatic alpha-cell function in trauma.

Authors:  A Lindsey; F Santeusanio; J Braaten; G R Faloona; R H Unger
Journal:  JAMA       Date:  1974-02-18       Impact factor: 56.272

8.  Cardiorespiratory, metabolic and endocrine changes after hemorrhage in man.

Authors:  J J Skillman; J Hedley-Whyte; J A Pallotta
Journal:  Ann Surg       Date:  1971-12       Impact factor: 12.969

9.  Blood sugar and insulin response of humans in shock.

Authors:  L C Carey; B D Lowery; C T Cloutier
Journal:  Ann Surg       Date:  1970-09       Impact factor: 12.969

Review 10.  Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shock.

Authors:  R Phillip Dellinger; Jean M Carlet; Henry Masur; Herwig Gerlach; Thierry Calandra; Jonathan Cohen; Juan Gea-Banacloche; Didier Keh; John C Marshall; Margaret M Parker; Graham Ramsay; Janice L Zimmerman; Jean-Louis Vincent; Mitchell M Levy
Journal:  Crit Care Med       Date:  2004-03       Impact factor: 7.598

View more
  9 in total

1.  Prevalence of comorbidity and its association with traumatic brain injury and outcomes in older adults.

Authors:  Hilaire J Thompson; Sureyya Dikmen; Nancy Temkin
Journal:  Res Gerontol Nurs       Date:  2011-12-14       Impact factor: 1.571

2.  Finding the sweet spot: identification of optimal glucose levels in critically injured patients.

Authors:  Matthew E Kutcher; Marci B Pepper; Diane Morabito; Dharma Sunjaya; M Margaret Knudson; Mitchell Jay Cohen
Journal:  J Trauma       Date:  2011-11

3.  Development and validation of the mortality risk for trauma comorbidity index.

Authors:  Hilaire J Thompson; Frederick P Rivara; Avery Nathens; Jin Wang; Gregory J Jurkovich; Ellen J Mackenzie
Journal:  Ann Surg       Date:  2010-08       Impact factor: 12.969

4.  Hyperglycemia and Elevated Lactate in Trauma: Where Do We Go From Here?

Authors:  Melissa L Bellomy; Robert E Freundlich
Journal:  Anesth Analg       Date:  2018-03       Impact factor: 5.108

5.  Relationship of hyperglycemia and surgical-site infection in orthopaedic surgery.

Authors:  Justin E Richards; Rondi M Kauffmann; Scott L Zuckerman; William T Obremskey; Addison K May
Journal:  J Bone Joint Surg Am       Date:  2012-07-03       Impact factor: 5.284

Review 6.  [Treatment of polytrauma in the intensive care unit].

Authors:  V Mann; S Mann; G Szalay; M Hirschburger; R Röhrig; C Dictus; T Wurmb; M A Weigand; M Bernhard
Journal:  Anaesthesist       Date:  2010-08       Impact factor: 1.041

7.  Stress-induced hyperglycemia as a risk factor for surgical-site infection in nondiabetic orthopedic trauma patients admitted to the intensive care unit.

Authors:  Justin E Richards; Rondi M Kauffmann; William T Obremskey; Addison K May
Journal:  J Orthop Trauma       Date:  2013-01       Impact factor: 2.512

8.  A systematic scoping review on the consequences of stress-related hyperglycaemia.

Authors:  Elena Olariu; Nicholas Pooley; Aurélie Danel; Montserrat Miret; Jean-Charles Preiser
Journal:  PLoS One       Date:  2018-04-06       Impact factor: 3.240

9.  AICAR Administration Attenuates Hemorrhagic Hyperglycemia and Lowers Oxygen Debt in Anesthetized Male Rabbits.

Authors:  Yi Huang; Paul H Ratz; Amy S Miner; Victoria A Locke; Grace Chen; Yang Chen; Robert W Barbee
Journal:  Front Physiol       Date:  2017-09-13       Impact factor: 4.566

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.